Workflow
MarketWatch
icon
Search documents
McDonald's says value meals are bringing back customers, as results lift stock
MarketWatch· 2026-02-11 21:46
McDonald's reported the fastest growth in comparable sales, both in the U.S. and globally, in more than two years. ...
Why Amazon's AI spending triggered the stock's worst slide in over a year
MarketWatch· 2026-02-11 21:23
Core Viewpoint - Amazon's significant investment in AI, amounting to $200 billion, has caused concern among investors, leading to a 16% decline in its stock price, although some analysts believe this investment could yield substantial returns in the future [1] Group 1: Investment Impact - The $200 billion AI spending plan has raised alarms among investors, resulting in a notable selloff of 16% in Amazon's stock [1] - Despite the immediate negative reaction from the market, there are optimistic views that the long-term benefits of this investment could outweigh the current risks [1] Group 2: Market Reaction - The selloff reflects investor apprehension regarding the scale of Amazon's financial commitment to AI technology [1] - Analysts are divided, with some expressing skepticism about the feasibility of such a large investment, while others see potential for significant growth and innovation [1]
The latest jobs report is bad news if you're looking for work — except in these fields
MarketWatch· 2026-02-11 18:39
Group 1 - The jobs report for January exceeded Wall Street expectations, providing a temporary boost to stock markets [1] - Despite the positive stock market reaction, the report contained disappointing data for many unemployed Americans seeking work [1]
Trump: I hiked Swiss tariffs because their president was rude to me
MarketWatch· 2026-02-11 17:59
Is it a national-security matter if a foreign leader speaks in a way the president doesn't like? ...
Why investors aren't loving this January jobs report
MarketWatch· 2026-02-11 17:33
Core Insights - Volatility has returned to Wall Street, driven by a surprisingly strong jobs report for January [1] Group 1 - The strong jobs report is a central factor contributing to the day's market turbulence [1]
Micron's stock pops. Here's what an executive just said to calm nervous investors.
MarketWatch· 2026-02-11 17:30
Core Viewpoint - The memory-chip maker has commenced high-volume production of its HBM4 and has started shipping to customers, as stated by CFO Mark Murphy [1] Group 1 - The company is actively producing HBM4 memory chips in large quantities [1] - Shipments of HBM4 to customers have already begun [1]
Why Amazon's $6.5 billion chip deal with Astera Labs is a ‘double-edged sword'
MarketWatch· 2026-02-11 16:22
Core Viewpoint - Astera Labs' shares declined despite exceeding fourth-quarter earnings expectations, as investors expressed skepticism regarding the value of a significant deal with Amazon [1] Group 1: Earnings Performance - Astera Labs reported a fourth-quarter earnings beat, indicating stronger-than-expected financial performance [1] Group 2: Investor Sentiment - Investors raised concerns about the rationale behind the large deal with Amazon, leading to a drop in share prices [1]
20 stocks of companies that delivered a double dose of growth this earnings season
MarketWatch· 2026-02-11 15:45
Companies in the S&P 500 achieving double-digit sales growth while improving profit margins include Palantir, Micron, Boeing and Alphabet. ...
Moderna's work developing seasonal vaccines is ‘risky' under current FDA, analyst says
MarketWatch· 2026-02-11 15:44
Core Viewpoint - Moderna's development of seasonal vaccines is considered 'risky' due to the FDA's refusal to review its mRNA-based flu vaccine application, reflecting a conflict between the company's mRNA-centric approach and the U.S. government's changing stance on mRNA technology [1] Group 1: Company Challenges - Moderna faces increasing pressure to expand its business as COVID-19 vaccine sales decline [1] - The FDA's decision not to review the flu vaccine application is a significant setback for Moderna's mRNA development efforts [1] - The company has described the FDA's communication as "inconsistent," indicating potential challenges in regulatory interactions [1] Group 2: Industry Context - The situation highlights the broader risks associated with mRNA technology in the current regulatory environment [1] - Analysts suggest that the shifting views of the U.S. government on mRNA technology pose risks for companies like Moderna that are heavily invested in this area [1]
Coal stocks gain as Trump looks set to issue executive order calling for industry deals with military
MarketWatch· 2026-02-11 15:42
Core Viewpoint - Coal stocks experienced an increase following the announcement that President Donald Trump intends to sign an executive order that may benefit the coal industry [1] Group 1 - The executive order is expected to provide support to the coal industry, which has been facing challenges in recent years [1] - The news has positively impacted coal stock prices, indicating investor optimism regarding potential regulatory relief [1]